Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
2 | Current Molecular Pharmacology | journal | 0.996 Q2 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | 28.00 | |
3 | Current Gene Therapy | journal | 0.951 Q2 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | 41.06 | |
4 | Current Drug Targets | journal | 0.906 Q3 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
5 | Analytical Cellular Pathology | journal | 0.886 Q3 | 35 | 11 | 75 | 553 | 160 | 75 | 2.28 | 50.27 | 34.55 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q3 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | 43.09 | |
7 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | 48.82 | |
8 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.513 Q3 | 45 | 28 | 71 | 1457 | 91 | 64 | 1.13 | 52.04 | 38.68 | |
9 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.423 Q4 | 39 | 28 | 79 | 1570 | 121 | 64 | 1.30 | 56.07 | 48.96 | |
10 | Infectious Disorders - Drug Targets | journal | 0.323 Q4 | 61 | 28 | 88 | 886 | 82 | 76 | 0.95 | 31.64 | 40.19 | |
11 | Open Medicinal Chemistry Journal | journal | 0.281 Q4 | 23 | 15 | 11 | 649 | 10 | 11 | 0.71 | 43.27 | 43.28 | |
12 | Current Computer-Aided Drug Design | journal | 0.259 Q4 | 32 | 33 | 116 | 1263 | 99 | 100 | 0.74 | 38.27 | 35.48 | |
13 | Letters in Drug Design and Discovery | journal | 0.247 Q4 | 37 | 149 | 371 | 5398 | 362 | 368 | 0.89 | 36.23 | 43.22 | |
14 | International Journal of Molecular and Cellular Medicine | journal | 0.242 Q4 | 22 | 36 | 30 | 1111 | 27 | 27 | 0.90 | 30.86 | 46.00 | |
15 | Current Pharmaceutical Analysis | journal | 0.224 Q4 | 27 | 70 | 143 | 1998 | 106 | 134 | 0.75 | 28.54 | 49.42 | |
16 | Current Enzyme Inhibition | journal | 0.197 Q4 | 19 | 21 | 56 | 1234 | 36 | 50 | 0.65 | 58.76 | 32.14 | |
17 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 11 | 81 | 742 | 13 | 68 | 0.06 | 67.45 | 29.79 | |
18 | Turkish Journal of Pharmaceutical Sciences | journal | 0.131 Q4 | 22 | 46 | 112 | 1826 | 38 | 112 | 0.26 | 39.70 | 53.85 | |
19 | Current Pharmacogenomics and Personalized Medicine | journal | 0.123 Q4 | 20 | 16 | 56 | 1195 | 7 | 52 | 0.05 | 74.69 | 58.33 | |
20 | Nanomedicine Research Journal | journal | 20 | 32 | 16 | 1108 | 20 | 16 | 1.25 | 34.63 | 31.68 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®